NCT07132606View on ClinicalTrials.gov

The Predictive Value of Serum Histone Succinylation in Malignant Solid Tumors

Not yet recruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

August 20, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

August 1, 2026

Conditions

Malignant Tumors

All Listed Sponsors

lead

Yinghua Ji

OTHER

NCT07132606 - The Predictive Value of Serum Histone Succinylation in Malignant Solid Tumors | Biotech Hunter | Biotech Hunter